A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic …

N Deng, LK Goh, H Wang, K Das, J Tao, IB Tan… - Gut, 2012 - gut.bmj.com
Objective Gastric cancer is a major gastrointestinal malignancy for which targeted therapies
are emerging as treatment options. This study sought to identify the most prevalent …

[HTML][HTML] DNA binding partners of YAP/TAZ

MK Kim, JW Jang, SC Bae - BMB reports, 2018 - ncbi.nlm.nih.gov
Hippo signaling plays critical roles in regulation of tissue homeostasis, organ size, and
tumorigenesis by inhibiting YES-associated protein (YAP) and PDZ-binding protein TAZ …

Integrative single-cell analysis of allele-specific copy number alterations and chromatin accessibility in cancer

CY Wu, BT Lau, HS Kim, A Sathe, SM Grimes… - Nature …, 2021 - nature.com
Cancer progression is driven by both somatic copy number aberrations (CNAs) and
chromatin remodeling, yet little is known about the interplay between these two classes of …

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis

R Chang, L Song, Y Xu, Y Wu, C Dai, X Wang… - Nature …, 2018 - nature.com
Loss of WW domain-containing oxidoreductase (Wwox) expression has been observed in
breast cancer (BC). However, its regulatory effects are largely unknown, especially in triple …

Targeted deletion of Wwox reveals a tumor suppressor function

RI Aqeilan, F Trapasso, S Hussain… - Proceedings of the …, 2007 - National Acad Sciences
The WW domain-containing oxidoreductase (WWOX) spans the second most common
fragile site of the human genome, FRA16D, located at 16q23, and its expression is altered in …

Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox

NP Mahajan, YE Whang, JL Mohler, HS Earp - Cancer research, 2005 - AACR
Aberrant activation of tyrosine kinases is linked causally to human cancers. Activated Cdc42-
associated kinase (Ack1), an intracellular tyrosine kinase, has primarily been studied for its …

WW domain–containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function

RI Aqeilan, V Donati, A Palamarchuk, F Trapasso… - Cancer research, 2005 - AACR
The WW domain–containing oxidoreductase, WWOX, is a tumor suppressor that is deleted
or altered in several cancer types. We recently showed that WWOX interacts with p73 and …

Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2γ transcription factor

RI Aqeilan, A Palamarchuk, RJ Weigel, JJ Herrero… - Cancer research, 2004 - AACR
The WWOX gene encodes a tumor suppressor WW domain-containing protein, Wwox.
Alterations of WWOX have been demonstrated in multiple types of cancer, and introduction …

WWOX: its genomics, partners, and functions

S Del Mare, Z Salah, RI Aqeilan - Journal of cellular …, 2009 - Wiley Online Library
The WW domain‐containing oxidoreductase (WWOX) spans one of the most active common
fragile sites (CFSs) involved in cancer, FRA16D. WWOX encodes a 46‐kDa protein that …

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple …

MW Jenner, PE Leone, BA Walker… - Blood, The Journal …, 2007 - ashpublications.org
We performed fluorescent in situ hybridization (FISH) for 16q23 abnormalities in 861
patients with newly diagnosed multiple myeloma and identified deletion of 16q [del (16q)] in …